Hinova Pharmaceuticals Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-199.5	-294.16	-301.51	-306.18
Depreciation & Amortization	5.97	6.42	5.47	3.05
Other Amortization	0.04	0.04	0.04	0.63
Loss (Gain) From Sale of Assets	0	0.01	0	0
Loss (Gain) From Sale of Investments	-13.11	-24.83	-28.89	-23.56
Other Operating Activities	-3.66	-2.78	-3.3	6.05
Change in Accounts Receivable	5.92	5.76	4.04	3.96
Change in Inventory	0	0	-0	-0
Change in Accounts Payable	-7.54	-21.85	-93.6	-20.6
Change in Other Net Operating Assets	24.79	75.88	102.82	108.82
Operating Cash Flow	-187.08	-255.51	-314.92	-227.82
Capital Expenditures	-89.55	-99.18	-69.21	-19.77
Sale of Property, Plant & Equipment	0	0.02	0	-
Investment in Securities	80	-25	-370	-
Other Investing Activities	-20.7	24.83	29.31	23.2
Investing Cash Flow	-30.25	-99.33	-409.9	3.42
Short-Term Debt Issued	-	0.5	30	-
Total Debt Issued	-	0.5	30	-
Short-Term Debt Repaid	-	-30.5	-	-0.5
Long-Term Debt Repaid	-4.06	-4.39	-3.4	-1.56
Total Debt Repaid	-4.06	-34.89	-3.4	-2.06
Net Debt Issued (Repaid)	-4.06	-34.39	26.6	-2.06
Issuance of Common Stock	-	-	1,010	-
Common Dividends Paid	-	-0.9	-	-2.56
Other Financing Activities	-	-	-19.31	-3.86
Financing Cash Flow	-4.06	-35.29	1,017	-8.48
Foreign Exchange Rate Adjustments	1.43	1.75	7.8	-1.99
Net Cash Flow	-219.96	-388.38	300.38	-234.87
Free Cash Flow	-276.63	-354.68	-384.13	-247.6
Free Cash Flow Margin	-75410.46%	-	-23269.07%	-
Free Cash Flow Per Share	-2.79	-3.58	-4.23	-3.33
Cash Interest Paid	-	-	3.92	-
Cash Income Tax Paid	0.44	-19.4	-13.46	-6.07
Levered Free Cash Flow	268.67	-230.86	-252.88	-145.13
Unlevered Free Cash Flow	269	-229.93	-250.43	-143.54
Change in Working Capital	23.17	59.79	13.27	92.19

Source: S&P Global Market Intelligence. Standard template. Financial Sources.